| Artificial virus delivers CRISPR-Cas9 system for genome editing of cells in mice L Li, L Song, X Liu, X Yang, X Li, T He, N Wang, S Yang, C Yu, T Yin, ... ACS nano 11 (1), 95-111, 2017 | 249 | 2017 |
| Immune checkpoint HLA-E: CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance X Liu, J Song, H Zhang, X Liu, F Zuo, Y Zhao, Y Zhao, X Yin, X Guo, X Wu, ... Cancer Cell 41 (2), 272-287. e9, 2023 | 169 | 2023 |
| Artificial intelligence-based multi-omics analysis fuels cancer precision medicine X He, X Liu, F Zuo, H Shi, J Jing Seminars in Cancer Biology 88, 187-200, 2023 | 155 | 2023 |
| Combination of immunotherapy with targeted therapy: theory and practice in metastatic melanoma C Yu, X Liu, J Yang, M Zhang, H Jin, X Ma, H Shi Frontiers in immunology 10, 990, 2019 | 130 | 2019 |
| Long non-coding RNAs: emerging roles in the immunosuppressive tumor microenvironment Y Luo, J Yang, J Yu, X Liu, C Yu, J Hu, H Shi, X Ma Frontiers in oncology 10, 48, 2020 | 72 | 2020 |
| Novel antimicrobial peptide–modified azithromycin-loaded liposomes against methicillin-resistant Staphylococcus aureus X Liu, Z Li, X Wang, Y Chen, F Wu, K Men, T Xu, Y Luo, L Yang International Journal of Nanomedicine, 6781-6794, 2016 | 70 | 2016 |
| Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer Y Zhao, X Liu, X Liu, J Yu, X Bai, X Wu, X Guo, Z Liu, X Liu Frontiers in Immunology 13, 955920, 2022 | 49 | 2022 |
| Single-cell transcriptomic profiling unravels the adenoma-initiation role of protein tyrosine kinases during colorectal tumorigenesis X Zheng, J Song, C Yu, Z Zhou, X Liu, J Yu, G Xu, J Yang, X He, X Bai, ... Signal Transduction and Targeted Therapy 7 (1), 60, 2022 | 48 | 2022 |
| MAPK‐Targeted drug delivered by a pH‐sensitive MSNP nanocarrier synergizes with PD‐1 blockade in melanoma without T‐cell suppression X Liu, Y Feng, G Xu, Y Chen, Y Luo, J Song, Y Bao, J Yang, C Yu, Y Li, ... Advanced Functional Materials 29 (12), 1806916, 2019 | 35 | 2019 |
| Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade X Liu, Y Feng, J Xu, Y Shi, J Yang, R Zhang, J Song, X Bai, X Wu, Y Bao, ... Journal of Controlled Release 332, 194-209, 2021 | 32 | 2021 |
| Application of artificial intelligence to the public health education X Wang, X He, J Wei, J Liu, Y Li, X Liu Frontiers in Public Health 10, 1087174, 2023 | 30 | 2023 |
| Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2 Y Luo, L Liu, Y Wu, K Singh, B Su, N Zhang, X Liu, Y Shen, S Huang Oncotarget 6 (6), 4286, 2015 | 27 | 2015 |
| Application of photo-responsive metal-organic framework in cancer therapy and bioimaging Y Zhao, X Jiang, X Liu, X Liu, Z Liu, X Liu Frontiers in Bioengineering and Biotechnology 10, 1031986, 2022 | 24 | 2022 |
| Improvement of PD-1 blockade efficacy and elimination of immune-related gastrointestinal adverse effect by mTOR inhibitor X Bai, X Wang, G Ma, J Song, X Liu, X Wu, Y Zhao, X Liu, Z Liu, W Zhang, ... Frontiers in Immunology 12, 793831, 2021 | 21 | 2021 |
| PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in triple-negative breast cancer X Wang, J Yu, X Liu, D Luo, Y Li, L Song, X Jiang, X Yin, Y Wang, L Chai, ... Cell Reports Medicine 3 (9), 2022 | 18 | 2022 |
| Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma J Yu, X Wu, J Song, Y Zhao, H Li, M Luo, X Liu Frontiers in Pharmacology 13, 928226, 2022 | 18 | 2022 |
| The evolution of acquired resistance to BRAFV600E kinase inhibitor is sustained by IGF1-driven tumor vascular remodeling G Xu, Y Luo, W Wu, X Liu, X Yu, Y Bao, X He, J Yu, Y Li, J Yang, R Zhang, ... Journal of Investigative Dermatology 142 (2), 445-458, 2022 | 15 | 2022 |
| A novel strategy to fuel cancer immunotherapy: targeting glucose metabolism to remodel the tumor microenvironment X Liu, Y Zhao, X Wu, Z Liu, X Liu Frontiers in Oncology 12, 931104, 2022 | 14 | 2022 |
| Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy T Xu, Z Liu, L Huang, J Jing, X Liu Frontiers in Immunology 13, 1057850, 2022 | 12 | 2022 |
| A novel benzothiazole derivative SKLB826 inhibits human hepatocellular carcinoma growth via inducing G2/M phase arrest and apoptosis Q Lei, L Zhang, Y Xia, T Ye, F Yang, Y Zhu, X Song, N Wang, Y Xu, X Liu, ... RSC Advances 5 (52), 41341-41351, 2015 | 12 | 2015 |
